Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002880581 | SCV003226874 | uncertain significance | Aortic valve disease 2 | 2022-10-18 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with SMAD6-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change results in a frameshift in the SMAD6 gene (p.Tyr264Serfs*275). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 233 amino acid(s) of the SMAD6 protein and extend the protein by 41 additional amino acid residues. |